This volume, with contributions from the most recognized experts in preventive strategies in breast cancer, presents the accepted as well as the novel ideas that have been introduced for the prevention of breast cancer.
There is no single preventive agent that can stop the incidence of breast cancer—the malignant disease most frequently diagnosed in women of all races and nationalities. Furthermore, its incidence around the globe is increasing in industrialized countries. The worldwide incidence of breast cancer has increased 30-40% since the 1970s, reaching an excess of 1,390,000 new cases and a mortality of more than 460,000 cases in 2015. Therefore, what is needed is the development of rational strategies for the prevention of this fatal disease.
Russo
Trends in Breast Cancer Prevention jetzt bestellen!
Weitere Infos & Material
1 The paradigms in breast cancer prevention.- 2 The role genistein in breast cancer prevention.- 3 The role of omega 3 in breast cancer prevention.- 4 Is there a role for Raloxifene and Tamoxifene for the prevention of breast cancer?.- 5 Aromatase inhibitors for breast cancer prevention.- 6 Inhibition of the estrogen metabolism pathways as a preventive strategy in hormone dependent cancer.- 7 The molecular mechanisms of the dual effect of pregnancy in risk and prevention of breast cancer.- 8 Beyond aspirin in breast cancer prevention.- 9 Role of anti-inflammatory drugs in the prevention of pregnancy associated breast cancer.- 10 Vaccination against breast cancer and it role in prevention.
Dr. Jose Russo is Professor and Senior Member of the Fox Chase Cancer Center. He is Director of the Irma H Russo Breast Cancer Research Laboratory and Director of the Breast Cancer and The Environment Research Center at the Fox Chase Cancer Center. Dr. Russo is also an Adjunct Professor of Pathology and Cell Biology at Jefferson Medical School and Professor in Biochemistry at Temple Medical School in Philadelphia, Pennsylvania.
He has authored more than 380 publications, including 11 books. He is member of several editorial boards of scientific journals and he has received numerous research awards from the National Cancer Institute of the National Institute of Health (NIH) of the United States, from the American Cancer Society and the Department of Defense for his original research in breast cancer.
For the last 35 years, Dr. Russo has been an active member of the NIH peer review system and has served as a special reviewer for the American Cancer Society, National Science Foundation, and the Department of Defense and Veteran Affairs. Dr. Russo has trained 55 Ph.D. and M.D. investigators in cancer research. He has received over 9,800 citations in his career.
